Security key
918385204
vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT)
CUSIP: 918385204
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Class A Common Stock, par value $0.01 per share
- Total 13F shares
- 333,650
- Total 13F value
- $7,850,341
- Share change
- +265,021
- SEC-reported price per share
- $23.53
- Number of holders
- 19
- Value change
- +$6,240,904
- Number of buys
- 10
- Number of sells
- 5
- Shares outstanding
- 3,911,217
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
19
Top holders
10
VTVT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
vTv Therapeutics Inc. SEC filings
vTv Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 918385204
Recent filing periods:
Ownership snapshot
Top reported holders of VTVT - vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Samsara BioCapital, LLC
Disclosed value leader
Ronald O Perelman
Comparable rows
14/15
Latest evidence
31 Dec 2023
13F
3/4/5
Lead comparable stake: 1%
1 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Samsara BioCapital, LLC leads the comparable SEC ownership view at 1%.
14 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Samsara BioCapital, LLC's linked filing trail.
Comparable ownership
Top 5
Samsara BioCapital, LLC
1%
VANGUARD GROUP INC
0.6%
BlackRock Finance, Inc.
0.03%
Tower Research Capital LLC (TRC)
0.03%
MORGAN STANLEY
0.02%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC |
13F
Company
|
1%
|
$470,212
40,888 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
0.6%
|
$270,469
23,519 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
0.03%
|
$15,422
1,341 shares
|
— | 31 Dec 2023 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.03%
|
$12,305
1,070 shares
|
— | 31 Dec 2023 |
| MORGAN STANLEY |
13F
Company
|
0.02%
|
$9,660
840 shares
|
— | 31 Dec 2023 |
| ROYAL BANK OF CANADA |
13F
Company
|
0.01%
|
$6,000
558 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
333,650
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2026 Across Filers
Q1 2026 holders
35
Q1 2024 holders
19
Holder diff
-16
| Investor | Q1 2026 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend